HBM Holdings (HKSE:02142) Operating Cash Flow per Share : HK$0.34 (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is HBM Holdings Operating Cash Flow per Share?

HBM Holdings's operating cash flow per share for the six months ended in Dec. 2024 was HK$-0.11. HBM Holdings's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.34.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for HBM Holdings's Operating Cash Flow per Share or its related term are showing as below:

During the past 7 years, HBM Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 49.50% per year. The lowest was -58.00% per year. And the median was -31.40% per year.

HKSE:02142's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 9.2
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

HBM Holdings Operating Cash Flow per Share Historical Data

The historical data trend for HBM Holdings's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HBM Holdings Operating Cash Flow per Share Chart

HBM Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-1.56

-1.34

-1.07

-0.20

0.31

HBM Holdings Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Operating Cash Flow per Share	Get a 7-Day Free Trial								-0.62	0.02	-0.22	0.45	-0.11

Competitive Comparison of HBM Holdings's Operating Cash Flow per Share

For the Biotechnology subindustry, HBM Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HBM Holdings's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HBM Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where HBM Holdings's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

HBM Holdings Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

HBM Holdings's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	238.457	/	772.457
	=	0.31

HBM Holdings's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )	=	Cash Flow from Operations (Q: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
	=	-88.648	/	805.904
	=	-0.11

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.34

HBM Holdings Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of HBM Holdings's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

HBM Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HBM Holdings Ltd (HKSE:02142) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

HBMHF:USA 6XY:Germany

Address

218 Xinghu Street, Suite 202, Building A3, Suzhou Industrial Park, Suzhou, CHN, 215123

Website

https://www.harbourbiomed.com

HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. The majority of the revenue for the firm is generated from the United States.

Executives

Wang Jingsong	2101 Beneficial owner
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Advantech Capital L.p.
Pang Kee Chan Hebert
Golden Link Investment Limited
Advantech Capital Partners Ltd.
Advantech Master Investment Limited
Astrazeneca Plc	2201 Interest of corporation controlled by you
Gic Private Limited	2102 Investment manager
The Capital Group Companies, Inc.	2201 Interest of corporation controlled by you
Gic (ventures) Pte. Ltd.	2201 Interest of corporation controlled by you
Gic Special Investments Private Limited	2102 Investment manager
Owap Investment Pte Ltd	2101 Beneficial owner
Advantech Capital Holdings Ltd.
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you

HBM Holdings Headlines

No Headlines